Overview

Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAP

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
1. This study will test the safety and efficacy of TG-873870 (Nemonoxacin) compared with Levofloxacin in adult patients with Community-Aquired Pneumonia (CAP) 2. To investigate the population pharmacokinetics (PPK) of nemonoxacin in adult patients with CAP after continuous oral administration and determine the pharmacokinetic (PK)/pharmacodynamic (PD).
Phase:
Phase 3
Details
Lead Sponsor:
TaiGen Biotechnology Co., Ltd.
Collaborators:
Parexel
PPD
Qualitix Clinical Research Co., Ltd.
Treatments:
Levofloxacin
Ofloxacin